Medtronic Receives CE Mark For Its Next Generation Cardiac Resynchronization Therapy-Pacemakers Post author:Sam Post published:February 23, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like FDA Formally Rejects Aradigm's Linhaliq, Requests a New Phase III Trial for Reconsideration January 28, 2018 Bayer Head of Discovery Exits as Drugmaker Combines Pharma R&D Unit November 29, 2017 Clinical-Stage Biotech Stock Might Outperform Amgen February 8, 2018
FDA Formally Rejects Aradigm's Linhaliq, Requests a New Phase III Trial for Reconsideration January 28, 2018